Advances in pediatric heart transplantation

Area of Science:

• Pediatric Cardiology
• Transplant Immunology
• Immunosuppressive Therapy

Background:

• Pediatric heart transplantation is a viable option for end-stage heart failure and complex congenital heart defects.
• Conventional surgical interventions are not always suitable for these complex cases.

Purpose of the Study:

• To review the current status of pediatric cardiac transplantation.
• To discuss recent advancements and emerging therapies in the field.

Main Methods:

• Literature review of pediatric cardiac transplantation studies.
• Analysis of recent advances in immunosuppressive therapies and their impact.

Main Results:

• Significant improvements in early mortality and short-term survival rates since the 1980s.
• High quality of life reported for most pediatric transplant recipients.
• Long-term mortality remains a challenge, primarily due to transplant-related coronary artery disease and graft failure.
• Renal dysfunction and posttransplant lymphoproliferative disorders are significant late morbidities linked to immunosuppression.
• Newer immunosuppressive agents (sirolimus, everolimus) show promise in mitigating long-term complications.

Conclusions:

• Novel immunosuppressive drugs offer potential to minimize renal complications and influence transplant vasculopathy progression.
• Advances in understanding posttransplant lymphoproliferative disorders are expected to improve diagnosis and treatment.